ArticleClinical ophthalmology (Auckland, N.Z.)2021
A Prospective, Comparative, Clinical Study to Evaluate the Safety and Efficacy of Two Different 0.1% Riboflavin Solutions Used in Collagen Crosslinking Treatment for Patients with Keratoconus.
Sheetal Brar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.